These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 18279105)

  • 1. Preparation and characterization of monopegylated human granulocyte-macrophage colony-stimulating factor.
    Lee DL; Sharif I; Kodihalli S; Stewart DI; Tsvetnitsky V
    J Interferon Cytokine Res; 2008 Feb; 28(2):101-12. PubMed ID: 18279105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site-specific PEGylation of engineered cysteine analogues of recombinant human granulocyte-macrophage colony-stimulating factor.
    Doherty DH; Rosendahl MS; Smith DJ; Hughes JM; Chlipala EA; Cox GN
    Bioconjug Chem; 2005; 16(5):1291-8. PubMed ID: 16173810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyethylene glycol (PEG)-modified granulocyte-macrophage colony-stimulating factor (GM-CSF) with conserved biological activity.
    Malik F; Delgado C; Knüsli C; Irvine AE; Fisher D; Francis GE
    Exp Hematol; 1992 Sep; 20(8):1028-35. PubMed ID: 1505637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural identification and biological activity of positional isomers of long-acting and mono-PEGylated recombinant human granulocyte colony-stimulating factor with trimeric-structured methoxy polyethylene glycol N-hydroxysuccinimidyl functional group.
    Son JP; Jun SW; Choi YK; Park HS; Son MK; Lee MY; Kang SH; Kang JS; Park YI
    Anal Biochem; 2012 Apr; 423(2):286-93. PubMed ID: 22244804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of PEGylation reaction time and molar ratio of rhG-CSF toward increasing bioactive potency of monoPEGylated protein.
    Behi J; Hassiki R; Said NB; Bouhaouala-Zahar B; Benkhoud ML
    Int J Biol Macromol; 2018 Apr; 109():888-895. PubMed ID: 29154875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PEGylated murine Granulocyte-macrophage colony-stimulating factor: production, purification, and characterization.
    Sainathan SK; Tu L; Bishnupuri KS; Han M; Li A; Newberry RD; McDonald KG; Crimmins DL; Houchen C; Anant S; Dieckgraefe BK
    Protein Expr Purif; 2005 Dec; 44(2):94-103. PubMed ID: 16213750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a Long-Acting Site-Specific PEGylated Murine GM-CSF Analog and Analysis of Its Hematopoietic Properties in Normal and Cyclophosphamide-Treated Neutropenic Rats.
    Cox GN; Lee JI; Rosendahl MS; Chlipala EA; Doherty DH
    Protein J; 2020 Apr; 39(2):160-173. PubMed ID: 32172395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproducible preparation and effective separation of PEGylated recombinant human granulocyte colony-stimulating factor with novel "PEG-pellet" PEGylation mode and ion-exchange chromatography.
    Yun Q; Yang RE; Chen T; Bi J; Ma G; Su Z
    J Biotechnol; 2005 Jul; 118(1):67-74. PubMed ID: 15904987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A highly stable polyethylene glycol-conjugated human single-chain antibody neutralizing granulocyte-macrophage colony stimulating factor at low nanomolar concentration.
    Krinner EM; Hepp J; Hoffmann P; Bruckmaier S; Petersen L; Petsch S; Parr L; Schuster I; Mangold S; Lorenczewski G; Lutterbüse P; Buziol S; Hochheim I; Volkland J; Mølhøj M; Sriskandarajah M; Strasser M; Itin C; Wolf A; Basu A; Yang K; Filpula D; Sørensen P; Kufer P; Baeuerle P; Raum T
    Protein Eng Des Sel; 2006 Oct; 19(10):461-70. PubMed ID: 16868004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low concentrations of recombinant granulocyte macrophage-colony stimulating factor derived from Chinese hamster ovary cells augments long-term bioactivity with delayed clearance in vitro.
    Hashimoto A; Tanaka T; Itoh Y; Yamagata A; Kitamura N; Tazawa R; Nakagaki K; Nakata K
    Cytokine; 2014 Aug; 68(2):118-26. PubMed ID: 24813650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new site-specific monoPEGylated filgrastim derivative prepared by enzymatic conjugation: Production and physicochemical characterization.
    Scaramuzza S; Tonon G; Olianas A; Messana I; Schrepfer R; Orsini G; Caliceti P
    J Control Release; 2012 Dec; 164(3):355-63. PubMed ID: 22735238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biotinylated granulocyte/macrophage colony-stimulating factor analogues: effect of linkage chemistry on activity and binding.
    Angelotti TP; Clarke MF; Longino MA; Emerson SG
    Bioconjug Chem; 1991; 2(6):466-74. PubMed ID: 1839606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release of PEGylated granulocyte-macrophage colony-stimulating factor from chitosan/glycerol films.
    Brown CD; Kreilgaard L; Nakakura M; Caram-Lelham N; Pettit DK; Gombotz WR; Hoffman AS
    J Control Release; 2001 May; 72(1-3):35-46. PubMed ID: 11389983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cysteine-specific PEGylation of rhG-CSF via selenylsulfide bond.
    Kunstelj M; Fidler K; Skrajnar S; Kenig M; Smilović V; Kusterle M; Caserman S; Zore I; Porekar VG; Jevševar S
    Bioconjug Chem; 2013 Jun; 24(6):889-96. PubMed ID: 23600957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PEGylated interferon-alpha2b: a branched 40K polyethylene glycol derivative.
    Ramon J; Saez V; Baez R; Aldana R; Hardy E
    Pharm Res; 2005 Aug; 22(8):1374-86. PubMed ID: 16078148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A sensitive WST-8-based bioassay for PEGylated granulocyte colony stimulating factor using the NFS-60 cell line.
    Tiwari K; Wavdhane M; Haque S; Govender T; Kruger HG; Mishra MK; Chandra R; Tiwari D
    Pharm Biol; 2015 Jun; 53(6):849-54. PubMed ID: 25423580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production and purification of recombinant human granulocyte-macrophage colony stimulating factor (GM-CSF) from high cell density cultures of Pichia pastoris.
    Bhatacharya P; Pandey G; Mukherjee KJ
    Bioprocess Biosyst Eng; 2007 Sep; 30(5):305-12. PubMed ID: 17453257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capillary electrophoretic separation of poly(ethylene glycol)-modified granulocyte-colony stimulating factor.
    Lee KS; Na DH
    Arch Pharm Res; 2010 Mar; 33(3):491-5. PubMed ID: 20361316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced circulation half-life of site-specific PEGylated rhG-CSF: optimization of PEG molecular weight.
    Zhai Y; Zhao Y; Lei J; Su Z; Ma G
    J Biotechnol; 2009 Jul; 142(3-4):259-66. PubMed ID: 19497340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEGylation markedly enhances the in vivo potency of recombinant human non-glycosylated erythropoietin: a comparison with glycosylated erythropoietin.
    Wang YJ; Hao SJ; Liu YD; Hu T; Zhang GF; Zhang X; Qi QS; Ma GH; Su ZG
    J Control Release; 2010 Aug; 145(3):306-13. PubMed ID: 20427020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.